These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21570511)

  • 1. Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
    Burke MA; Lee R; Fintel DJ
    Am Heart J; 2011 May; 161(5):832-41. PubMed ID: 21570511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
    J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
    Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
    Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
    Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
    J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Ebrahimi R; Dyke C; Mehran R; Manoukian SV; Feit F; Cox DA; Gersh BJ; Ohman EM; White HD; Moses JW; Ware JH; Lincoff AM; Stone GW
    J Am Coll Cardiol; 2009 May; 53(21):1965-72. PubMed ID: 19460609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary bypass surgery in patients treated with clopidogrel. Is it safe?
    Carrel T; Englberger L
    Curr Opin Cardiol; 2009 Nov; 24(6):539-43. PubMed ID: 19684514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
    Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
    Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients.
    Patel JH; Stoner JA; Owora A; Mathew ST; Thadani U
    Am J Cardiol; 2009 Jun; 103(12):1687-93. PubMed ID: 19539077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption.
    Johnston SS; Bell K; Gdovin J; Jing Y; Graham J
    Hosp Pract (1995); 2012 Feb; 40(1):15-23. PubMed ID: 22406879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.
    Mehta RH; Chen AY; Pollack CV; Roe MT; Zalenski RJ; Clements EA; Gibler WB; Ohman EM; Harrington RA; Peterson ED
    Am J Cardiol; 2006 Sep; 98(5):624-7. PubMed ID: 16923449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
    Husted S; Harrington RA; Cannon CP; Storey RF; Mitchell P; Emanuelsson H
    Int J Clin Pract; 2009 Apr; 63(4):667-70. PubMed ID: 19335707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes.
    Krimly A; Yan RT; Yan AT; DeYoung JP; Gallo R; Steg G; Eikelboom J; Gore JM; Fox KA; Fitchett D; Quantz MA; Goodman SG
    Can J Cardiol; 2011; 27(6):711-5. PubMed ID: 21875778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
    Rao RV; Goodman SG; Yan RT; Spencer FA; Fox KA; DeYoung JP; Rose B; Grondin FR; Gallo R; Gore JM; Yan AT;
    Am Heart J; 2009 Apr; 157(4):642-50.e1. PubMed ID: 19332190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.